Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BL3000 vs Pantogar for Telogen Effluvium in Women
NCT04880889Phase 3Unknown
- Sponsor
- Biolab Farmacêutica
- Start
- Jan 2023
- Primary completion
- Jul 2023
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of BL-3000 in telogen effluvium (TE), sponsored by Biolab Farmacêutica. Status: unknown.
02
Drugs
BL-3000
03
Conditions
telogen effluvium (TE)
Beyond the preview
Go deeper on NCT04880889.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04880889.